JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL)
Clinical trial NCT06514768 · RECRUITING
Trial details
- NCT number
- NCT06514768
- Sponsor
- 920th Hospital of Joint Logistics Support Force of People's Liberation Army of China
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-20
- Primary completion
- 2026-06-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.